Pollard, John R

Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR

Reaper, P. M., Griffiths, M. R., Long, J. M., Charrier, J.-D., MacCormick, S., Charlton, P. A., Golec, J. M. C., & Pollard, J. R. (2011) · Nature Chemical Biology

DNA Repair MechanismsPARP inhibition in cancer therapy

Cited by 633

ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A

Williamson, C. T., Miller, R., Pemberton, H. N., Jones, S. E., Campbell, J., Konde, A., Badham, N., Rafiq, R., Brough, R., Gulati, A., et al. (2016) · Nature Communications

Chromatin Remodeling and CancerDNA Repair Mechanisms

Cited by 382

Mechanism of glycogen synthase inactivation and interaction with glycogenin

Marr, L., Biswas, D., Daly, L. A., Browning, C., Vial, S. C. M., Maskell, D. P., Hudson, C., Bertrand, J. A., Pollard, J., Ranson, N. A., et al. (2022) · Nature Communications

Glycogen Storage Diseases and MyoclonusMetabolism, Diabetes, and Cancer

Cited by 47